Fundus albipunctatus is a rare, inherited eye disorder that primarily affects a person's ability to see in low-light conditions, a symptom commonly known as night blindness. The condition gets its name from its most distinctive physical feature: the presence of numerous tiny, whitish-yellow spots or "flecks" scattered across the retina, which is the light-sensitive tissue lining the back of the eye (the fundus).
Individuals with fundus albipunctatus typically experience night blindness from a very early age. The hallmark of this condition is delayed dark adaptation. This means that when moving from a brightly lit environment into a dark one—such as walking into a dark movie theater or driving into an unlit tunnel—it takes an unusually long time for the eyes to adjust. While a person with normal vision might adapt in a few minutes, someone with fundus albipunctatus may require hours to achieve their maximum level of night vision. However, once fully adapted, their night vision can significantly improve. In most cases, vision in bright light and color vision remain normal.
The condition is primarily caused by mutations in the RDH5 gene. This gene is responsible for producing an enzyme called 11-cis retinol dehydrogenase 5, which plays a crucial role in the "visual cycle"—the process by which light entering the eye is converted into electrical signals sent to the brain. Specifically, this enzyme helps recycle vitamin A molecules needed for vision in low light. When the enzyme doesn't function properly, the recycling process is delayed, leading to night blindness. The characteristic white-yellow flecks are believed to be accumulations of these unprocessed molecules.
Fundus albipunctatus is generally considered a stationary condition, meaning it does not typically lead to severe vision loss or total blindness over time. The flecks may even fade or change as a person ages, though the night blindness usually persists. However, in some cases, individuals may develop other retinal issues later in life, such as macular degeneration or cone dystrophy, which can affect central daytime vision.
Diagnosis is usually made through a comprehensive eye examination, where an ophthalmologist can observe the characteristic flecks. Specialized tests, such as electroretinography (ERG) and dark adaptometry, are used to measure the retina's electrical activity and the time it takes to adapt to darkness. Genetic testing can confirm the diagnosis by identifying mutations in the RDH5 gene.
While there is currently no cure for fundus albipunctatus, understanding the condition is the first step in managing it. Patients are encouraged to have regular eye exams to monitor their retinal health and to consult their healthcare provider or a retinal specialist for personalized advice and care.